UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061679
Receipt number R000070576
Scientific Title Machine learning-based prediction of lymph node metastases for individualized surgical decision-making in older patients with gastric cancer: A retrospective simulation study compliant with TRIPOD+AI
Date of disclosure of the study information 2026/05/25
Last modified on 2026/05/25 16:13:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Machine learning-based prediction of lymph node metastases for individualized surgical decision-making in older patients with gastric cancer: A retrospective simulation study compliant with TRIPOD+AI

Acronym

ML-based LNM prediction in GC

Scientific Title

Machine learning-based prediction of lymph node metastases for individualized surgical decision-making in older patients with gastric cancer: A retrospective simulation study compliant with TRIPOD+AI

Scientific Title:Acronym

ML-based LNM prediction in GC

Region

Japan


Condition

Condition

Gastric cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

(1) to develop and temporally validate an LNM prediction model based on preoperative variables in patients aged >=70 years using six machine learning algorithms
(2) to quantify the oncological safety [negative predictive value (NPV), false-negative count] of a threshold-guided reduced-surgery strategy via retrospective simulation
(3) to perform a comprehensive evaluation of calibration, fairness, and uncertainty compliant with the TRIPOD+AI reporting guidelines

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the area under the receiver operating characteristic curve (ROC-AUC) and area under the precision-recall curve (PR-AUC) of the model

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

70 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

patients aged 70 years and above who underwent gastrectomies with lymph node dissections for gastric cancer between April 1995 and March 2025.

Key exclusion criteria

(i) neoadjuvant chemotherapy
(ii) distant metastases (M1)

Target sample size

1405


Research contact person

Name of lead principal investigator

1st name Goshi
Middle name
Last name Fujimoto

Organization

Kameda Medical Center

Division name

Gastroenterological Surgery

Zip code

296-0041

Address

929 Higashi-cho, Kamogawa City, Chiba Prefecture 296-8602, Japan

TEL

0470922211

Email

g_chimera_7@yahoo.co.jp


Public contact

Name of contact person

1st name Goshi
Middle name
Last name Fujimoto

Organization

Kameda Medical Center

Division name

Gastroenterological Surgery

Zip code

296-0041

Address

929 Higashi-cho, Kamogawa City, Chiba Prefecture 296-8602, Japan

TEL

0470922211

Homepage URL


Email

g_chimera_7@yahoo.co.jp


Sponsor or person

Institute

Kameda Medical Center

Institute

Department

Personal name

Goshi Fujimoto


Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kameda Medical Center

Address

929 Higashi-cho, Kamogawa City, Chiba Prefecture 296-8602, Japan

Tel

0470922211

Email

g_chimera_7@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

静岡県


Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

1405

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2026 Year 05 Month 18 Day

Date of IRB

2026 Year 05 Month 18 Day

Anticipated trial start date

2026 Year 05 Month 18 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Final features are selected from the top-ranked features in LASSO and Random Forest. Logistic Regression (LR), Random Forest (RF), XGBoost (XGB), LightGBM (LGBM), CatBoost, and Multi-Layer Perceptron (MLP) are built after optimizing their hyperparameters.
Model evaluation is performed using Accuracy, Precision, Recall, F1 score, ROC-AUC, and PR-AUC. Calibration is quantitatively evaluated using a Calibration Plot, as well as the Brier Score, the expected-to-observed ratio, and the Hosmer-Lemeshow (HL) test.
Simulations of reduced surgery indications at thresholds of 5%, 10%, and 20% will be performed to calculate the negative predictive value (NPV, with 95% CI), number of false negatives, and rate of candidates for local resection. Decision Curve Analysis (DCA) will be performed using the method by Vickers et al. to calculate the net benefit.
SHAP (SHapley Additive Explanations) analysis will be performed on all models.


Management information

Registered date

2026 Year 05 Month 25 Day

Last modified on

2026 Year 05 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070576